World News | Press Trust of India | Wednesday November 30, 2022
A new, single-dose oral treatment for sleeping sickness is 95 per cent effective in adults and adolescents, regardless of disease stage, according to a study published in The Lancet Infectious Diseases.
www.ndtv.com